Fluconazole therapy in Candida albicans spondylodiscitis
Related Experiment Video
Updated: Oct 24, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
P Rössel1, H C Schønheyder, H Nielsen
1Department of Medical Gastroenterology, Aalborg Hospital, Denmark.
Abstract:
A case of Candida albicans spondylodiscitis in a 20-year-old female liver transplant recipient is reported. The patient was successfully treated with sequential therapy with liposomal amphotericin B and fluconazole. A review of the literature showed 10 cases of Candida albicans spondylodiscitis successfully treated either with fluconazole alone or a sequential therapy with amphotericin B and fluconazole. If long-term amphotericin B therapy is not feasible, a prolonged course of fluconazole in a daily dose of 200-400 mg may be considered as an alternative.
Related Concept Videos
Candidiasis
Cryptococcal Meningitis
Fungal Phylum Microsporidia
Antifungal Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

